- Home
- EBON vs CING Comparison
EBON vs CING Comparison
Compare EBON & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- CING
- Stock Information
- Founded
- EBON 2010
- CING 2012
- Country
- EBON China
- CING United States
- Employees
- EBON N/A
- CING N/A
- Industry
- EBON Semiconductors
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- CING Health Care
- Exchange
- EBON Nasdaq
- CING Nasdaq
- Market Cap
- EBON 25.3M
- CING 26.7M
- IPO Year
- EBON 2020
- CING 2021
- Fundamental
- Price
- EBON $4.11
- CING $4.05
- Analyst Decision
- EBON
- CING Strong Buy
- Analyst Count
- EBON 0
- CING 4
- Target Price
- EBON N/A
- CING $30.67
- AVG Volume (30 Days)
- EBON 11.2K
- CING 139.2K
- Earning Date
- EBON 08-22-2025
- CING 08-19-2025
- Dividend Yield
- EBON N/A
- CING N/A
- EPS Growth
- EBON N/A
- CING N/A
- EPS
- EBON N/A
- CING N/A
- Revenue
- EBON $5,868,771.00
- CING N/A
- Revenue This Year
- EBON N/A
- CING N/A
- Revenue Next Year
- EBON N/A
- CING N/A
- P/E Ratio
- EBON N/A
- CING N/A
- Revenue Growth
- EBON 20.88
- CING N/A
- 52 Week Low
- EBON $3.00
- CING $1.80
- 52 Week High
- EBON $10.94
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- EBON 47.56
- CING 36.31
- Support Level
- EBON $3.80
- CING $4.01
- Resistance Level
- EBON $4.33
- CING $5.74
- Average True Range (ATR)
- EBON 0.27
- CING 0.41
- MACD
- EBON -0.08
- CING -0.18
- Stochastic Oscillator
- EBON 25.83
- CING 2.30
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.